Affiliation:
1. Dalian Medical University
2. China Medical University
3. Dalian Municipal Central Hospital, Dalian University of Technology
Abstract
AbstractBackground Dexmedetomidine is crucial for preventing postoperative delirium and cognitive dysfunction and improving the quality of life of surgical patients. However, the effects of dexmedetomidine on these complications in different anesthesia methods have not been thoroughly evaluated. Thus, we conducted a meta-analysis to assess its impact on postoperative delirium and cognitive dysfunction. Methods We searched PubMed, Embase, and Cochrane Library for randomized controlled trials comparing intravenous dexmedetomidine to other interventions in preventing postoperative delirium and cognitive dysfunction in non-cardiac and non-neurosurgical patients. Statistical analysis and graphing were performed using Review Manager, STATA, the second version of the Cochrane risk-of-bias tool for randomized controlled trials, and GRADE profiler. Main results This meta-analysis comprised a total of 24 randomized controlled trials, including 20 trials assessing postoperative delirium and 6 trials assessing postoperative cognitive dysfunction. In these 20 studies, a positive correlation was found between intravenous infusion of dexmedetomidine and the lower incidence of postoperative delirium (RR: 0.55; 95%CI: 0.47 to 0.64, p< 0.00001, I2= 2%) and postoperative cognitive dysfunction(RR: 0.60; 95%CI: 0.38 to 0.96, p = 0.03, I2= 60%). Subgroup analysis did not reveal a significant difference in the incidence of postoperative delirium between the general anesthesia and non-general anesthesia groups, but a significant difference was observed in the incidence of postoperative cognitive dysfunction. However, pooled data showed that the use of dexmedetomidine increased the incidence of hypotension (RR: 1.42; 95%CI:1.08 to 1.86,p=0.01, I2= 0%) and bradycardia (RR: 1.66; 95%CI: 1.23 to 2.26,p=0.001, I2= 0%) compared with other interventions but there is no significantly higher occurrence of hypertension in DEX groups (RR=1.35, 95% CI :0.81–2.24, p=0.25, I2= 0%). Conclusion Intravenous dexmedetomidine infusion during non-cardiac and non-neurosurgical procedures may significantly reduce the risk of postoperative delirium and cognitive dysfunction compared to other interventions. Subgroup analysis revealed a consistent preventive effect on postoperative delirium in both general and non-general anesthesia groups, while continuous infusion during general anesthesia was more effective in reducing the risk of cognitive dysfunction. However, hypotension and bradycardia were more frequent in patients who received dexmedetomidine during surgery.
Publisher
Research Square Platform LLC
Reference46 articles.
1. MacLullich AMJ, Ferguson KJ, Miller T, de Rooij SEJA, Cunningham C. Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. Journal of Psychosomatic Research. 2008 Sep 1;65(3):229–38.
2. Scott JE, Mathias JL, Kneebone AC. Incidence of delirium following total joint replacement in older adults: a meta-analysis. General Hospital Psychiatry. 2015 May 1;37(3):223–9.
3. Risk Factors and Incidence of Postoperative Delirium in Elderly Chinese Patients;Dai YT;GER,2000
4. Predictors of Cognitive Dysfunction after Major Noncardiac Surgery;Monk TG;Anesthesiology. 2008 Jan
5. Postoperative Störungen der kognitiven Leistungsfähigkeit bei älteren Patienten Die Ergebnisse der „International Study of Postoperative Cognitive Dysfunction” (ISPOCD 1);Biedler A;Anaesthesist,1999